In summary, the present study explored the mechanism by which leonurine ameliorated NAFLD by inhibiting hepatic lipid synthesis via the ADRA1a/AMPK/SCD1 axis. This evidence concerns the gene ADRA1A and metabolic dysfunction-associated steatotic liver disease.